Our researchers and clinicians are constantly challenging traditional models of cancer care to create space for new possibilities. This means earlier detection, improved diagnostics, targeted treatments and real hope for patients and their loved ones, but without seed-funding, new ideas can stall.

Through donation to this program you'll join a select group of investors who work directly with some of the brightest minds at The Princess Margaret to decide which research gets funding and what innovative ideas will help shape the future of cancer care.
Invest in Research
Minimum $10K donation to become a member

$2 million raised to date has helped leverage
almost $36 million of additional funding.



This speaks to the power of donor commitment. Since the beginning, for every $1 committed by donors, this investment helps to bring in $18 of additional funding.
See past recipients

Stand on the forefront of innovation

Your Invest in Research commitment will give you:

A vote on which
projects receive funding

The first look at
findings & discoveries

Invites to
exclusive events

Invest in Research

Your gift today will help fund the daring and bold ideas that change the way cancer is treated here in Canada and around the world.
“Research is critical to everything and Invest in Research enabled us to take a lab-based concept to the clinic for new therapies. Providing an opportunity for emerging and established scientists to collaborate and test ideas can lead to extraordinary insights and potential discoveries. When we invest in research, we automatically invest in our own care, in our people, and in our patients.”
- Dr. Aaron Schimmer, Director of Research, Princess Margaret Cancer Centre

Investments in research are changing the game

Each year, $100,000 is awarded to researchers at Princess Margaret Cancer Centre after donors vote on the projects that receive support.
Learn how our past recipients are leading the way in cancer care.


Lung Treatment

In 2010, Dr. Thomas Waddell and Dr. Marcelo Cypel received an Invest in Research grant to test the revolutionary idea of targeting chemotherapy directly to the lungs to improve survival rates and extend the period of time patients can live cancer free. Patient trials began in 2016 and the doctors hope they can treat more people with a variety of cancers that have spread to the lungs in the next five years.                                                                                                                                                     

Leukemia Cells

Dr. Schimmer and his team are investigating a new ways to kill Leukemia cells without harming normal cells or organs. Preliminary tests secured an opportunity to collaborate with Takeda Pharmaceuticals and develop the world’s first drug of this nature. This work will lead to first-in-human clinical trials to treat patients with relapsed and refractory acute myeloid Leukemia (AML). The team has secured $2 million in additional support to continue this work.

Uncovering the Root of Renal Cell Carcinoma

Dr. Laurie Ailles received a grant in 2010 to determine if renal cell carcinoma stem cells are rare or common in kidney cancer. The first step was to develop resources derived from patient tumours, which included developing methods for growing patient’s cancer cells in culture and in mice. The project also received a Canadian Cancer Society grant (2015-2018) and work is continuing in this area.                                                                                                                                          

Past Recipients

Dr. Phedias Diamandis - Growing Artificial Human Brains to Refine Glioblastoma Drug Development Efforts
Dr. Marianne Koritzinsky - Mechanisms of PRDX4 addiction in pancreatic cancer
Read More
22 projects have been funded to date and hundreds more are on the horizon.
Each one holds the promise of discovery. With your help we can enable Future Care Now.

Ready to Invest?   Invest in Research


Karina Wong
Manager, Leadership Giving
The Princess Margaret Cancer Foundation
Email: karina.wong@thepmcf.ca